Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Clinical Research

Prognostic value of connexin43 expression in patients with clinically localized prostate cancer

Prostate Cancer and Prostatic Diseases volume 14, pages 90–95 (2011)Cite this article

Subjects

Abstract

Connexins (Cxs) are a family of transmembrane proteins that build cell-to-cell channels in gap junctions. Gap junctions composed of Cxs have an essential role in intercellular communication, adhesion and cell differentiation. Several studies investigated the role of connexin43 (Cx43) in different carcinomas; however, none investigated its prognostic role in prostate cancer. Cx43 expression and relationship with established prognostic features were assessed in a cohort of 102 patients treated with radical prostatectomy for clinically localized prostate adenocarcinoma. Cx43 expression in prostate cancer was significantly associated with established features indicative of worse prognosis, such as follow-up time (P<0.001) and preoperative PSA (P<0.007). Patients with lower Cx43 expressions in tumours have shorter follow-up time, which indicated shorter disease-free survival and higher preoperative PSA values. Furthermore, tumours with positive surgical margins (P<0.001) showed significantly lower Cx43 expression compared with tumours without this feature. In univariate (P<0.001) and multivariate (P=0.014) analyses, decreased Cx43 expression was found to be a significant predictor of biochemical recurrence free-survival. Study results show the association of decreased Cx43 expression with prostate cancer progression. Moreover, Cx43 could serve as an additional prognostic marker and used together with traditional prognostic markers might help in further stratifying the risk of disease progression in patients with prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Fukushima M, Hattori Y, Yoshizawa T, Maitani Y . Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice. Int J Oncol 2007; 30: 225–231.

    CAS  PubMed  Google Scholar 

  2. Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, Ross BA . Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet 1999; 24: 91–110.

    Article  CAS  PubMed  Google Scholar 

  3. Wang M, Berthoud VM, Beyer EC . Connexin43 increases the sensitivity of prostate cancer cells to TNFα-induced apoptosis. J Cell Sci 2007; 120: 320–329.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Govindarajan R, Zhao S, Song XH, Guo RJ, Wheelock M, Johnson KR et al. Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its migration by α-catenin. J Biol Chem 2002; 277: 50087–50097.

    Article  CAS  PubMed  Google Scholar 

  5. Vinken M, Decrock E, De Vuyst E, Ponsaerts R, D′hondt C, Bultynck G et al. Connexins: sensors and regulators of cell cycling. Biochim Biophys Acta 2010; (e-pub ahead of print) doi:10.1016/j.bbcan.2010.08.004.

    Article  CAS  Google Scholar 

  6. Brehm R, Ruttinger C, Fischer P, Gashaw I, Winterhager E, Kliesch S et al. Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells. Neoplasia 2006; 8: 499–509.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Habermann H, Ray V, Habremann W, Prins GS . Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer. J Urol 2002; 167: 655–660.

    Article  PubMed  Google Scholar 

  8. Carruba G, Stefano R, Cocciadiferro L, Saladino F, Di Cristina A, Tokar E et al. Intercellular communication and human prostate carcinogenesis. Ann N Y Acad Sci 2002; 963: 156–168.

    Article  CAS  PubMed  Google Scholar 

  9. Li Z, Zhou Z, Welch DR, Donahue HJ . Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis 2008; 25: 893–901.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Xu HT, Li QC, Zhang YX, Zhao Y, Liu Y, Yang ZQ et al. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem Cytobiol 2008; 46: 315–321.

    Article  CAS  PubMed  Google Scholar 

  11. Hossain MZ, Jagdale AB, Ao P, LeCiel C, Huang RP, Boynton AL . Impaired expression and posttranslational processing of connexin43 and downregulation of gap junctional communication in neoplastic human prostate cells. Prostate 1999; 38: 55–59.

    Article  CAS  PubMed  Google Scholar 

  12. Decrock E, Vinken M, De Vuyst E, Krisko DV, D'Herde K, Vanhaecke T et al. Connexin-related signaling in cell death: to live or let die? Cell Death Differ 2009; 16: 524–536.

    Article  CAS  PubMed  Google Scholar 

  13. Tsai H, Werber J, Davia MO, Edelman M, Tanaka KE, Melman A et al. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Bichem Biophys Res Commun 1996; 227: 64–69.

    Article  CAS  Google Scholar 

  14. Sobin LH, Wittekind C (eds). International Union Against Cancer (UICC): TNM classification of malignant tumours, 5th ed. Wiley Liss: New York, USA, 1997.

    Google Scholar 

  15. Umhauer S, Ruch RJ, Fanning J . Gap junctional intercellular communication and connexin 43 expression in ovarian carcinoma. Am J Obstet Gynecol 2000; 182: 999–1000.

    Article  CAS  PubMed  Google Scholar 

  16. Nomura S, Maeda K, Noda E, Inoue T, Fukunaga S, Nagahara H et al. Clinical significance of the expression of connexin 26 in colorectal cancer. J Exp Clin Cancer Res 2010; 29: 79.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Liu X, Furuya T, Li D, Xu J, Cao X, Li Q et al. Connexin 26 expression correlates with less aggressive phenotype of intestinal type-gastric carcinomas. Int J Mol Med 2010; 25: 709–716.

    CAS  PubMed  Google Scholar 

  18. Inose T, Kato H, Kimura H, Faried A, Tanaka N, Sakai M et al. Correlation between connexin 26 expression and poor prognosis of esophageal squamous cell carcinoma. Ann Surg Oncol 2009; 16: 1704–1710.

    Article  PubMed  Google Scholar 

  19. Conklin C, Huntsman D, Yorida E, Makretsov N, Turbin D, Bechberger JF et al. Tissue microarray analysis of connexin expression and its prognostic significance in human breast cancer. Cancer Lett 2007; 255: 284–294.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Varaždin General Hospital, Varaždin, Croatia

    G Benko

  2. University Department of Urology, Sestre Milosrdnice University Hospital, Zagreb, Croatia

    B Spajić & G Štimac

  3. University Department of Pathology, Sestre Milosrdnice University Hospital, Zagreb, Croatia

    A Demirović, B Krus̆lin & D Tomas

  4. School of Medicine, University of Zagreb, Zagreb, Croatia

    B Krus̆lin & D Tomas

Authors
  1. G Benko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Spajić
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Demirović
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Štimac
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Krus̆lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Tomas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Tomas.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Benko, G., Spajić, B., Demirović, A. et al. Prognostic value of connexin43 expression in patients with clinically localized prostate cancer. Prostate Cancer Prostatic Dis 14, 90–95 (2011). https://doi.org/10.1038/pcan.2010.51

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2010.51

Keywords

This article is cited by

Search

Advanced search

Quick links